Galderma Teams with ZO Skin Health; Upgrades Aspire Loyalty Program

Lisa Johnston
Senior Editor
Lisa Johnston profile picture
The Aspire Galderma Rewards mobile app
The Aspire Galderma Rewards mobile app

Dermatology company Galderma is giving its aesthetics portfolio a shot in the arm.

Efforts to boost the category include new digital enhancements to its Aspire Galderma Rewards loyalty program, growing its U.S. sales team by 15%, and launching a collaboration with premium skincare brand ZO Skin Health.

The Aspire Galderma Rewards updates will offer aesthetic providers and their patients a simpler and more convenient way to leverage the benefits of the loyalty program. Designed to strengthen the provider-patient relationship, Aspire has served over 1.4 million members since its inception in 2015.

"We want to enable every customer and partner to build experiences on our leading platforms," said Alisa Lask, vice president and general manager of Galderma U.S. aesthetics. "At Galderma, we're relentlessly focused on driving trust and success for our customers. The acceleration of our growth and expansion plans underscores Galderma's commitment to the growing aesthetics market."

Other changes include:

New Aspire Galderma Rewards Android and Apple app: Patients can now manage their Aspire points and rewards from their mobile device, as well as receive offers and savings, and select their preferred providers.

Improved Electronic Medical Record Integration: Aspire will soon be more seamlessly integrated with common electronic medical records used in the aesthetic market. Features will roll out in Q2 with refreshes planned throughout 2020 and beyond.

DTC Marketing Amplification: Galderma has expanded the Restylane direct-to-consumer advertising campaign nationally to drive consumers into providers' offices. The campaign has already doubled the number of people looking for a Restylane aesthetic provider, the company said.

Galderma rebranded from Nestlé Skin Health in 2019, when it was acquired by a consortium of investors including the EQT VIII fund, Luxinva (a wholly-owned subsidiary of Abu Dhabi Investment Authority, PSP Investments and others. 

It's now present in over 100 countries with a product portfolio encompassing prescription medicines, aesthetics solutions and consumer care products. Consumer brands in its umbrella include Cetaphil, Proactiv and Differin.

Join the conversation!


More on Loyalty Marketing